Berenberg initiated coverage of Medacta Group with a Buy rating and CHF 150 price target. The firm’s channel checks with surgeons and industry executives have given it confidence that the business can continue to grow well ahead of the broader market in the medium term.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MEDGF: